Valuation: Pathkey.AI Ltd

Market Cap 21.61M 15.2M 13.57M 12.54M 11.36M 21.26M 1.44B 151M 59.73M 756M 57.03M 55.82M 2.38B P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 18.2M 12.8M 11.43M 10.56M 9.57M 17.9M 1.21B 127M 50.3M 637M 48.03M 47.01M 2.01B EV / Sales 2025
21.1x
EV / Sales 2026 1,648x
Free-Float
17.5%
Yield 2025 *
-
Yield 2026 -
1 week-15.79%
Current month-40.74%
1 month-38.46%
3 months-48.39%
6 months-56.76%
1 week 0.02
Extreme 0.015
0.02
1 month 0.02
Extreme 0.015
0.03
Current year 0.02
Extreme 0.015
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.15
10 years 0.01
Extreme 0.014
2.5
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-15.79%-20.00%-63.64% 15.2M
+0.55%+0.10%+20.62%+54.50% 249B
+0.52%+3.64%+5.24%+20.10% 162B
+0.22%+4.84%-17.61%+75.01% 157B
-0.51%+1.13%-55.52%-8.48% 66.22B
-1.05%+1.39%+8.63%+68.94% 52.3B
+0.75%+2.78%-14.77%-8.54% 52.18B
+0.97%+3.19%+11.36%+43.36% 51.34B
+1.45%+3.55%+20.02%+68.66% 48.79B
+0.65%+5.69%+30.48%+87.76% 44.57B
Average +0.35%+0.33%-1.16%+33.77% 88.35B
Weighted average by Cap. +0.39%+1.40%+2.43%+46.05%

Financials

2025 2026
Net sales 322K 226K 202K 187K 169K 317K 21.5M 2.25M 890K 11.26M 850K 832K 35.51M 47.63K 33.5K 29.92K 27.64K 25.05K 46.86K 3.18M 333K 132K 1.67M 126K 123K 5.25M
Net income -1.45M -1.02M -909K -840K -761K -1.42M -96.66M -10.11M -4M -50.64M -3.82M -3.74M -160M -3.65M -2.57M -2.29M -2.12M -1.92M -3.59M -244M -25.5M -10.1M -128M -9.64M -9.44M -403M
Net Debt -25.17K -17.7K -15.81K -14.6K -13.23K -24.76K -1.68M -176K -69.57K -880K -66.43K -65.01K -2.78M -3.41M -2.4M -2.14M -1.98M -1.79M -3.35M -228M -23.81M -9.43M -119M -9M -8.81M -376M
Projected Income Statement - Annual - Pathkey.AI Ltd
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
26/10/26 A$0.0160 0.00% 542,967
23/10/26 A$0.0160 -11.11% 2,036,977
22/10/26 A$0.0180 0.00% 1,409,412
21/10/26 A$0.0180 -10.00% 1,154,245
20/10/26 A$0.0200 0.00% 14,918